Quick Order Cart

Cat. No. ARG36485

GSDMD Knockout NCI-H1299 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Lung

  • Disease:

    Carcinoma

The GSDMD Knockout NCI-H1299 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting gasdermin D in the human NSCLC cell line NCI-H1299, a metastatic, p53-deficient lung adenocarcinoma model. GSDMD is the effector of pyroptosis, cleaved by inflammatory caspases such as caspase-1 downstream of NLRP3 inflammasome activation, leading to membrane pore formation and release of IL-1?? and IL-18. This knockout model enables functional dissection of GSDMD-dependent pyroptosis and inflammasome signaling, and is ideal for drug screening and mechanistic studies in the context of lung cancer biology. Applications include LDH release, cytokine ELISA, western blotting, and cell death imaging assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    NCI-H1299

    Sex of Donor

    Male

    Age

    43 years

    Gene Name

    GSDMD

    Gene Identifier

    NCBI Gene ID 79792

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The GSDMD Knockout NCI-H1299 Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal knockout cell population for the gasdermin D (GSDMD) gene in the human non-small cell lung carcinoma (NSCLC) line NCI-H1299. This polyclonal pool provides a heterogeneous gene-disrupted model suitable for population-level loss-of-function studies without clonal isolation.

The NCI-H1299 cell line originates from a lymph node metastasis of lung adenocarcinoma and serves as a widely used in vitro model for NSCLC metastasis. These adherent epithelial cells harbor a p53 deficiency, which supports their transformed and metastatic characteristics, enabling investigation of tumor progression and therapy resistance mechanisms.

GSDMD acts as the executioner of pyroptosis, a pro-inflammatory programmed cell death. Inflammasome activation triggers caspase-1, caspase-4, or caspase-5 to cleave GSDMD, removing its autoinhibitory C-terminal domain. The liberated N-terminal fragment then oligomerizes, forming membrane pores that cause cell swelling, lysis, and release of IL-1??, IL-18, and DAMPs. Upstream, NLRP3 and AIM2 inflammasomes recruit ASC to activate caspase-1, while cytosolic LPS activates caspase-4/5. NF-??B transcriptionally primes NLRP3 and pro-IL-1?? expression.

This knockout model enables dissection of pyroptosis in p53-deficient NSCLC. GSDMD loss allows researchers to study how pyroptotic signaling affects metastatic behavior, apoptotic sensitivity, and immune interactions in lung cancer. It also facilitates exploration of GSDMD-independent cytokine release and alternative cell death pathways, providing insights into compensatory mechanisms. Emerging data suggest pyroptosis can exert both anti-tumor and pro-tumor effects, making this model valuable for investigating context-dependent roles of inflammatory cell death.

Applications include mechanistic pyroptosis research, inflammasome signaling studies, and screening for pyroptosis modulators. Researchers can employ western blotting for GSDMD cleavage, LDH release assays, ELISA for IL-1??/IL-18, caspase-1 activity measurements, immunofluorescence for pore formation, flow cytometry, and morphological imaging. The polyclonal knockout pool is also suited for co-culture systems examining pyroptosis-driven immune responses. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)